Cargando…
Molecular Docking and Pharmacological Investigations of Rivastigmine-Fluoxetine and Coumarin–Tacrine hybrids against Acetyl Choline Esterase
The present AChE inhibitors have been successful in the treatment of Alzheimer׳s Diseases however suffers serious side effects. Therefore in this view, the present study was sought to identify compounds with appreciable pharmacological profile targeting AChE. Analogue of Rivastigmine and Fluoxetine...
Autores principales: | Babitha, Pallikkara Pulikkal, Sahila, Mohammed Marunnan, Bandaru, Srinivas, Nayarisseri, Anuraj, Sureshkumar, Sivanpillai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574120/ https://www.ncbi.nlm.nih.gov/pubmed/26420918 http://dx.doi.org/10.6026/97320630011378 |
Ejemplares similares
-
Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
por: Sahila, Mohammed Marunnan, et al.
Publicado: (2015) -
Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer’s Disease
por: Pulikkal, Babitha Pallikkara, et al.
Publicado: (2017) -
Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia
por: Marunnan, Sahila Mohammed, et al.
Publicado: (2017) -
Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition
por: Sinha, Chanda, et al.
Publicado: (2014) -
Structural basis for the in vitro known acyl-depsipeptide 2 (ADEP2) inhibition to Clp 2 protease from Mycobacterium tuberculosis
por: Khandekar, Natasha, et al.
Publicado: (2016)